| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |